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TRPM2 channel deficiency prevents delayed cytosolic
Zn2+ accumulation and CA1 pyramidal neuronal death
after transient global ischemia
M Ye1,5, W Yang*,1,2,5, JF Ainscough3, X-P Hu1, X Li2, A Sedo2, X-H Zhang1, X Zhang1, Z Chen1, X-M Li1, DJ Beech2,3, A Sivaprasadarao2,
J-H Luo*,1 and L-H Jiang*,2,4
Transient ischemia is a leading cause of cognitive dysfunction. Postischemic ROS generation and an increase in the cytosolic Zn2+
level ([Zn2+]c) are critical in delayed CA1 pyramidal neuronal death, but the underlying mechanisms are not fully understood. Here
we investigated the role of ROS-sensitive TRPM2 (transient receptor potential melastatin-related 2) channel. Using in vivo and
in vitro models of ischemia–reperfusion, we showed that genetic knockout of TRPM2 strongly prohibited the delayed increase in
the [Zn2+]c, ROS generation, CA1 pyramidal neuronal death and postischemic memory impairment. Time-lapse imaging revealed
that TRPM2 deficiency had no effect on the ischemia-induced increase in the [Zn2+]c but abolished the cytosolic Zn
2+ accumulation
during reperfusion as well as ROS-elicited increases in the [Zn2+]c. These results provide the first evidence to show a critical role
for TRPM2 channel activation during reperfusion in the delayed increase in the [Zn2+]c and CA1 pyramidal neuronal death and
identify TRPM2 as a key molecule signaling ROS generation to postischemic brain injury.
Cell Death and Disease (2014) 5, e1541; doi:10.1038/cddis.2014.494; published online 27 November 2014
Transient ischemia is a major cause of chronic neurological
disabilities including memory impairment and cognitive
dysfunctions in stroke survivors.1,2 The underlying mechan-
isms are complicated and multiple, and remain not fully
understood.3 It is well documented in rodents, non-human
primates and humans that pyramidal neurons in the CA1
region of the hippocampus are particularly vulnerable and
these neurons are demised after transient ischemia, com-
monly referred to as the delayed neuronal death.4 Studies
using in vitro and in vivo models of transient ischemia have
demonstrated that an increase in the [Zn2+]c or cytosolic Zn
2+
accumulation is a critical factor.5–11 There is evidence
supporting a role for ischemia-evoked release of vesicular Zn2
+ at glutamatergic presynaptic terminals and subsequent entry
into postsynaptic neurons via GluA2-lacking AMPA subtype
glutamate receptors (AMPARs) to raise the [Zn2+]c.
12–16 Upon
reperfusion, while glutamate release returns to the preische-
mia level,17 Zn2+ can activate diverse ROS-generating
machineries to generate excessive ROS as oxygen becomes
available, which in turn elicits further Zn2+ accumulation during
reperfusion.18,19 ROS generation and cytosolic Zn2+
accumulation have a critical role in driving delayed CA1
pyramidal neuronal death,7,12,20–22 but themolecular mechan-
isms underlying such a vicious positive feedback during
reperfusion remain poorly understood.
Transient receptor potential melastatin-related 2 (TRPM2)
forms non-selective cationic channels; their sensitivity to
activation by ROS via a mechanism generating the channel
activator ADP-ribose (ADPR) confers diverse cell types
including hippocampal neurons with susceptibility to ROS-
induced cell death, and thus TRPM2 acts as an important
signalingmoleculemediating ROS-induced adversities such as
neurodegeneration.23–26 Emergent evidence indeed supports
the involvement of TRPM2 in transient ischemia-induced CA1
pyramidal neuronal death.27–30 This has been attributed to the
modulation of NMDA receptor-mediated signaling; despite that
ROS-induced activation of the TRPM2 channels results in no
change in the excitability of neurons from the wild-type (WT)
mice, TRPM2 deficiency appeared to favor prosurvival synaptic
Glu2A expression and inhibit prodeath extrasynaptic GluN2B
expression.30 A recent study suggests that TRPM2 activation
results in extracellular Zn2+ influx to elevate the [Zn2+]c.
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The present study, using TRPM2-deficient mice in conjunction
with in vivo and in vitro models of transient global ischemia,
provides compelling evidence to show ROS-induced TRPM2
activation during reperfusion as a crucial mechanism determin-
ing the delayed cytosolic Zn2+ accumulation, CA1 neuronal
death and postischemic memory impairment.
Results
TRPM2 channels are functionally expressed in hippo-
campal pyramidal neurons. We first examined TRPM2
expression by immunofluorescent staining of hippocampal
brain slices and neuron cultures. Strong TRPM2 immuno-
staining was present in hippocampal neurons (Supplementary
Figure 1), particularly in pyramidal neurons identified by the
expression of calmodulin-dependent kinase II (CaMKII)
(Figure 1a). Whole-cell patch-clamp recordings of CA1
pyramidal neurons in hippocampus slices documented
ADPR-induced inward currents, which were inhibited by
clotrimazole, a TRPM2 channel inhibitor23 (Figure 1b).
ADPR-induced currents were also observed in the cultured
WT hippocampal neurons, as reported by a previous study,32
but were absent in the TRPM2-knockout (KO) hippocampal
neurons (Figure 1c). These results are consistent in confirming
the functional TRPM2 channel expression in CA1 pyramidal
neurons.32
TRPM2 deficiency prevents CA1 pyramidal neuronal
death induced by transient ischemia. TRPM2 deficiency
caused no discernible effect on the number of hippocampal
neurons and GFAP-positive glial cells during development
(Supplementary Figures 2a–c). In addition, there was no
significant difference in the body weight of adult WT and
TRPM2-KO mice. The survival rate of WT and TRPM2-KO
mice was examined over a period of 72 h after being
subjected to bilateral common carotid artery occlusion
(BCCAO) followed by reperfusion, an in vivo model of
transient global ischemia. The survival rate was 54% for the
BCCAO-operated WT mice, which was significantly lower
than the survival rate of 90% observed in BCCAO-operated
TRPM2-KO mice (Po0.05) (Figure 2a). To examine the
contribution of TRPM2 in delayed CA1 pyramidal neuronal
death, we analyzed the neuronal loss in hippocampal slices
from the mice survived 72 h after BCCAO operation (Figures
2b–e). Nissl staining disclosed a huge number of damaged or
dead pyramidal neurons in the CA1 region in the BCCAO-
operated WT mice (373±72/0.2 mm2, n=8), but very few
damaged neurons in the sham-operated WT mice (9.0± 3.5,
n= 5) (Figures 2b and e). The number of damaged neurons
was markedly reduced in the BCCAO-operated TRPM2-KO
mice (156± 48, n=9) (Figures 2b and e). Conversely, NeuN
staining revealed many more CA1 pyramidal neurons in the
TRPM2-KO mice (236± 31/0.2 mm2, n=9) than in the WT
mice after BCCAO operation (46± 20, n=8) (Figures 2c and
d). These results clearly demonstrate that TRPM2 has an
important role in mediating transient ischemia-induced
delayed neuronal death.
TRPM2 deficiency protects memory impairment after
transient ischemia. It is well established that the CA region
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Figure 1 TRPM2 expression in hippocampal pyramidal neurons. (a) Representative immunofluorescent images showing expression of TRPM2 in CaMKII-positive pyramidal
neurons in the hippocampus including CA1 region. DAPI (4',6-diamidino-2-phenylindole) staining and merged images are also shown. (b) Representative traces showing 1 mM
ADPR-induced inward current in WT hippocampal brain slices that was inhibited by 20 μM clotrimazole (CLT). The solid line above the current recording denotes the zero current
level. The holding membrane potential was− 60 mV. Summary of the currents recorded using intracellular solutions with or without ADPR are shown on the right. (c) Mean inward
currents induced by 1 mM ADPR in cultured WTor TRPM2-KO hippocampal neurons. The holding membrane potential was − 60 mV. The number of neurons recorded for each
case is shown within parentheses. ***Po0.005 for comparison of indicated groups
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in the hippocampus is pivotal for learning and memory. We
thus evaluated whether TRPM2 deficiency can also protect
against transient ischemia-induced memory impairment. The
WT and TRPM2-KO mice had similar locomotor function and
exploratory ability as assessed by the open-field test
(Supplementary Figure 3). However, the WT and TRPM2-
KO mice after BCCAO exhibited significant difference
revealed by the novelty environment habituation test
(Figures 3a and b). Unlike the sham-operated WT mice that
showed reduced activities in exploring the pre-exposed
environment (66.4±8.3% of the first time, n=6), the
BCCAO-operated WT mice exhibited significantly increased
activities (131.9±11.6%, n=5; not significantly different from
the activities during the first test), indicating memory
impairment (Figure 3b). In striking contrast, the TRPM2-KO
mice displayed similar and reduced activities after BCCAO
(71.1±12.2%, n=6) or sham operation (63.0± 10.9%, n= 7)
(Figure 3b).
We also examined the spatial memory with the water maze
test (Figures 3c and d). Following a 5-day training session, the
latency to find the escape platform was progressively
shortened for both WT and TRPM2-KO mice. At the end of
the training session, the latency was however significantly
longer for the BCCAO-operated WT mice (36.8± 4.5 s, n=7)
than the sham-operated WT (15.3± 2.7 s, n= 8; Po0.01)
(Figure 3c), confirming impaired learning ability. In contrast,
there was no difference in the latency for the BCCAO-operated
(18.7± 5.2 s, n= 7) and sham-operated TRPM2-KO mice
(14.3± 1.8 s, n=7) (Figure 3c), indicating that TRPM2
deficiency prevented such learning impairment. During the
probe test in which the escape platformwas removed, the time
the mice used to search for the missing platform in the target
quadrant was recorded to determine the spatial memory
(Figure 3d). The BCCAO-operated WT mice spent signifi-
cantly less time in the targeted quadrant (18.6±3.5%, n= 7) in
comparison with the sham-operated WT mice (34.1± 5.0%,
n=8; Po0.05), suggesting impaired spatial memory as
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Figure 2 TRPM2 deficiency protects delayed CA1 pyramidal neuronal death induced by transient global ischemia. (a) Summary of the survival rate for WTand TRPM2-KO
mice during 72 h after BCCAO operation. The number of mice used for each case is shown within parentheses. (b and c) Representative images showing Nissl (b) or NeuN (b)
staining of hippocampal slices. The areas in the rectangle boxes are shown in enlarged images underneath. (d and e) Quantitative analysis of NeuN-positive (d) and damaged
neurons (e) in BCCAO- or sham-operated WT and TRPM2-KO mice as shown in (b and c). The number of mice used for each case is shown within parentheses in (e).
***Po0.005 for comparisons within WT or TRPM2-KO mice; †††Po0.005 for comparison between WT and TRPM2-KO mice
Role of ROS-sensitive TRPM2
M Ye et al
3
Cell Death and Disease
reported by previous studies.33 However, there was no
significant difference in the time the TRPM2-KO mice spent
in the targeted quadrant after sham (38.7±7.8%, n=7) and
BCCAO operation (31.2± 5.3%, n= 7) (Figure 3d).
Taken together, these in vivo studies provide strong
evidence to support a crucial role for TRPM2 in mediating
memory impairment after transient ischemia.
TRPM2 deficiency prevents delayed increase in the
[Zn2+]c. As mentioned above, there is strong evidence to
support the delayed increase in the [Zn2+]c as a key factor
driving CA1 neuronal death.3,5,9,10,11,14,34–37 Moreover,
using single-cell imaging and tetracycline (Tet)-inducible
TRPM2-stable HEK293 cells, we found that H2O2 evoked a
modest but significant increase in the [Zn2+]c in extracellular
Zn2+-free solutions and a further 45-fold increase upon
introduction to extracellular Zn2+-containing solutions in
TRPM2-expressing cells (Tet+), and, in contrast, there was
virtually no H2O2-induced increase in the [Zn
2+]c in uninduced
cells (Tet−) (Supplementary Figure 4). These results are
consistent with a recent study that suggests that TRPM2
channel activation results in increases in the [Zn2+]c.
38 We
therefore hypothesized that TRPM2 deficiency protects the
delayed neuronal death by preventing TRPM2-dependent
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Figure 3 TRPM2 deficiency prevents memory impairment induced by transient global ischemia. (a) Representative tracking traces in novelty environment habituation test.
BCCAO or sham operation was introduced after the second test. (b) Summary of the locomotor activities as shown in (a). **Po0.01 for comparison between the activities during
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training session. The number of mice examined for each case is shown within parentheses. ††Po0.01 for comparisons between BCCAO-operated WT mice and other three
groups of mice. (d) Summary of the percentage of time searching the escape platform in the target quadrant during the probe test. *Po0.05 for comparison between sham- and
BCCAO-operated WT mice and NS, no significant difference for indicated comparisons. The number of mice examined for each case is shown within parentheses in (b) for
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increases in the [Zn2+]c during reperfusion. To test this
hypothesis, we performed Nissl and TSQ double staining of
hippocampal slices from the WT and TRPM2-KO mice 72 h
after BCCAO operation to determine postischemic [Zn2+]c
and cell death in CA1 pyramidal neurons (Figure 4). Neuronal
death in the SP layer was clearly accompanied by an
increase in the [Zn2+]c in the BCCAO-operated WT mice
(Figure 4a), and such increases in neuronal death and the
[Zn2+]c were nearly abolished in the BCCAO-operated
TRPM2-KO mice (Figure 4b). Further detailed analysis
indicates that the [Zn2+]c was significantly increased in the
BCCAO-operated WT mice (37.2± 8.0, n=3) compared with
the sham-operated WT mice (4.3± 0.5, n= 3) (Figure 4c).
Such an increase was remarkably suppressed in the
BCCAO-operated TRPM2-KO mice (11.1±3.8, n=3). The
[Zn2+]c in the BCCAO-operated TRPM2-KO mice appeared to
increase compared with the sham-operated TRPM2-KO mice
(1.7± 0.3, n= 3), but the increase was not statistically
significant (P40.05). We also examined the [Zn2+]c in the
WTand TRPM2-KO mice at 24 and 48 h, as well as 72 h after
BCCAO operation. The increase in the [Zn2+]c in the WT mice
became discernible at 48–72 h but not at 24 h
(Supplementary Figure 5), supporting that TRPM2 deficiency
prevents the delayed increase in the [Zn2+]c.
To further corroborate these findings, we also used oxygen/
glucose deprivation–reperfusion (OGD-R), an in vitromodel of
transient ischemia, in acute hippocampal brain slices
(Figure 5a). There were low Zn2+ fluorescence and neuronal
death in the control slices that were similar between WT and
TRPM2-KO mice (Figures 5b and c), likely resulting from slice
preparations. OGD-R induced increases in both the [Zn2+]c
and pyramidal neuronal death in the WT slices as reported
previously,8,13 and both responses were absent in the
TRPM2-KO slices (Figures 5b and c).
Therefore, our studies using in vivo and in vitro models of
transient ischemia provide consistent evidence to indicate that
TRPM2 has an important role in the delayed increase in the
[Zn2+]c and cell death in CA1 pyramidal neurons. Recent
studies have reported that the zinc transporters (ZnT1, ZnT2,
ZnT3 and ZnT6) and TRPM7 channel are involved in the
regulation of Zn2+ homeostasis in the brain.11,39,40 We
performed real-time RT-PCR to test whether TRPM2
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Figure 4 TRPM2 deficiency prevents delayed increases in the [Zn2+]c and CA1 pyramidal neuronal death after transient global ischemia. (a and b) Representative images of
TSQ (blue) and Nissl staining of hippocampal brain slices from BCCAO- or sham-operated WT (a) and TRPM2-KO mice (b). SR, SP and SO represent the stratum radiatum,
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*Po0.05 and NS, no significant difference, for comparisons within WT or TRPM2-KO mice; †Po0.05 for comparison between BCCAO-operated WT and TRPM2-KO mice
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deficiency altered their expression. There was no significant
difference at the mRNA level in the hippocampus of WT and
TRPM2-KO mice (Supplementary Figure 6), suggesting no
major role for these Zn2+-regulating mechanisms in attenuat-
ing the delayed increase in the [Zn2+] and the protection
against pyramidal neuronal death as a result of TRPM2
deficiency.
TRPM2 deficiency abolishes reperfusion- and ROS-induced
increase in the [Zn2+]c. To understand mechanistically how
TRPM2 is engaged in the delayed increase in the [Zn2+]c,
we used time-lapse confocal imaging to monitor the
temporal changes in the [Zn2+]c during OGD-R in cultured
hippocampal neurons from the WT and TRPM2-KO mice.
OGD induced a robust increase in the [Zn2+]c in the WT
neurons (Figures 6a and b). Such an increase was
completely inhibited using CaEDTA, a membrane-
impermeable and specific Zn2+ chelator,14,15 or Naspm, a
GluR2-lacking AMPAR-selective antagonist16 (Figures 6a–c).
The TRPM2-KO neurons exhibited similar basal [Zn2+]c and
OGD-induced increase in the [Zn2+]c as the WT neurons
(Figures 6a and b). These results confirm a critical role for
AMPARs,13,14,16 and also exclude a role for TRPM2 in
elevating the [Zn2+]c during ischemia. In stark contrast with
the sustained [Zn2+]c in the WT neurons upon reperfusion,
the [Zn2+]c in the TRPM2-KO neurons declined rapidly,
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2+ influx during ischemia in cultured hippocampal neurons.
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returning almost to the basal level in 10min (Figures 6a and c).
Consistent with the well-established fact that reperfusion
generates excessive ROS,41 our results provide the first
evidence to show ROS-sensitive TRPM2 channel as a
molecular mechanism that is exclusively required for the
delayed increase in the [Zn2+]c or cytosolic Zn
2+ accumulation
during reperfusion.
To testify directly whether TRPM2 activation underpins
ROS-induced increase in the [Zn2+]c, we monitored the [Zn
2+]c
in cultured hippocampal neurons during exposure to H2O2
(Figure 7). H2O2 at 100–300 μM evoked a salient increase in
the [Zn2+]c, leading to Zn
2+ accumulation in some punctate
structures in the WT neurons as reported previously.42 Such
H2O2-induced increase in the [Zn
2+]c was strongly attenuated
by TPEN, a selective Zn2+ chelator (Figures 7a and c). More
evidently, H2O2-induced Zn
2+ responses were completely
absent in the TRPM2-KO neurons (Figures 7b and c), further
supporting an essential role of TRPM2 in ROS-induced
increase in the [Zn2+]c.
TRPM2 deficiency attenuates ROS production. As men-
tioned above, Zn2+ can activate diverse ROS-generating
machineries to generate excessive ROS as oxygen becomes
available during reperfusion.18,19 We were interested in
whether the loss of TRPM2-dependent increase in the [Zn2+]c
led to a reduction in ROS production after transient
ischemia. Thus, we detected the superoxide production
in situ in the CA1 region 3.5, 24, 48 and 72 h after BCCAO
operation. As expected, in the WT mice, there was a strong
increase in ROS production at 3.5 h that was reduced over
the next 72 h (Figure 8 and Supplementary Figure 7). The
ROS production occurred noticeably earlier than the
increases in the [Zn2+]c (cf. Supplementary Figure 5). The
ROS production in the BCCAO-operated TRPM2-KO mice
was also increased, but the ROS level was significantly
attenuated in comparison with that detected in the BCCAO-
operated TRPM2-KO mice over the same period of examina-
tion time (Figure 8 and Supplementary Figure 7). These
results indicate that TRPM2 is critical for ROS production
during reperfusion.
Discussion
The present study, using TRPM2-deficient mice in conjunction
with in vivo and in vitromodels of transient ischemia, hasmade
several important findings that support a critical role for
TRPM2 activation during reperfusion in determining delayed
increases in the [Zn2+]c, CA pyramidal neuronal death, and
memory impairments. First, TRPM2 deficiency protected
against CA1 pyramidal neuronal death induced by transient
ischemia (Figures 2,4 and 5), which are in agreement with
recent reports.27–30 Second, preventing transient ischemia-
induced CA1 pyramidal neuronal death by TRPM2 deficiency
offers strong protection of postischemia memory impairments
as assessed by novelty environment habituation test and
water maze test (Figure 3), supporting a critical role of
TRPM2-dependent CA1 pyramidal neuronal death in the
development of learning and memory deficits. Third, TRPM2
was required for the increase in the [Zn2+]c (Figure 4) and ROS
generation (Figure 8) during reperfusion. Finally, TRPM2 was
essential for ROS-induced delayed increase in the [Zn2+]c in
hippocampal neurons (Figure 7) as well as ROS-induced
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Figure 7 TRPM2 deficiency abolishes H2O2-induced increase in the [Zn
2+]c in cultured hippocampal neurons. (a and b) Representative images showing [Zn
2+]c in cultured
hippocampal neurons from WTand TRPM2-KO mice before (basal) and during exposure to 300 μM H2O2. The WT neurons were further exposed to 10 μM TPEN for 10 min. The
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increase in the [Zn2+]c in HEK293 cells (Supplementary Figure 3).
Taken together, these findings provide a novel mechanistic
insight into the molecular processes underlying transient
ischemia-induced brain injury.
It is well established that ischemia–reperfusion leads to the
generation of excessive ROS and increases in the [Zn2+]c,
which in turn causes delayed CA1 pyramidal neuronal death
and postischemic brain injury.2,3,19,41 The underlying Zn2+
signaling mechanisms are not fully understood. Presynaptic
Zn2+ release and subsequent cytosolic accumulation via
Zn2+-permeable channels and particularly GluR2-lacking
AMPARs represent a well-recognized mechanism.13–17,33
There is accumulating evidence to support synaptic presence
of GluR2-lacking AMPARs in CA1 pyramidal neurons,43–48
including a recent study that shows that transient ischemia
induces a fast endocytosis of GluA2 subunit and insertion of
GluA1 subunit in cultured hippocampal pyramidal neurons.49
The finding from the present study that OGD-induced increase
in the [Zn2+]c was prevented by removing extracellular Zn
2+ by
CaEDTA or by GluA2-lacking AMPAR-specific antagonist
Naspm (Figures 6a and b) is highly consistent with the notion
of GluA2-lacking AMPARs in hippocampal CA1 pyramidal
neurons as the Zn2+ influx pathway during ischemia.13–16
TRPM2 deficiency did not alter the basal [Zn2+]c and ischemia-
induced increase in the [Zn2+]c, strongly excluding a role for
TRPM2 in mediating ischemia-induced in the [Zn2+]c
(Figure 6b). In striking contrast, TRPM2 deficiency caused
rapid loss of the cytosolic Zn2+ upon reperfusion (Figure 6c),
revealing an exclusive role for the TRPM2 activation during
reperfusion in the delayed increases in the [Zn2+]c (Figure 4
and Supplementary Figure 6). This finding is well reconciled
with the facts that reperfusion provides oxygen, which the
ROS-generating machineries need to generate ROS during
reperfusion37 (Figure 8 and Supplementary Figure 7), and that
TRPM2 is an important ROS sensor22–25 and activation of
TRPM2 channels leads to increases in the [Zn2+]c.
30
Furthermore, consistent with the notion that Zn2+ can induce
further ROS production via activating various ROS-generating
mechanisms,8,13,19,20,21,39,47 TRPM2 deficiency strongly but
incompletely suppressed ROS generation (Figure 8). Selec-
tive loss of cytosolic Zn2+ accumulation as a result of TRPM2
deficiency also attenuated ROS production during reperfusion
(Supplementary Figure 7) and potent neuronal protection
(Figures 2–5), and provided compelling evidence to suggest
TRPM2 activation during reperfusion is a key step initiating a
vicious positive feedback mechanism driving the delayed
increase in the [Zn2+]c and cell death in CA1 pyramidal
neurons and memory impairments after transient ischemia.
Such an exclusive role of TRPM2 during reperfusion
predicts that TRPM2 deficiency can only protect against brain
damage induced by transient (followed by reperfusion) but not
permanent (no reperfusion) ischemia, which has been shown
in a recent study.29 The postischemic TRPM2-dependent Zn2+
mechanism revealed in the present study can also explain
satisfactorily why removal of Zn2+ by CaEGTA15 or pharma-
cological inhibition of TRPM227 after transient ischemia was
also effective in preventing the delayed CA1 pyramidal
neuronal death.15,27 The present study shows that TRPM2 is
present on hippocampal pyramidal neurons (Figure 1), but
whether it also has intracellular localization, as found in other
cell types,50 remains to be investigated. Further studies are
required to determine the sources responsible for the increase
in the [Zn2+]c during reperfusion and the mechanisms
responsible for further ROS production. H2O2-induced
increase in the [Zn2+]c in cultured hippocampal neurons was
observed in extracellular Zn2+-free solutions (Figure 7) and, as
suggested previously,51 may result at least in part from
intracellular Zn2+ release. It should be mentioned that TRPM2
is expressed in glial cells as well as in neurons in the brain;23
non-neuronal TRPM2 may also be involved in neuronal death
induced by transient ischemia, and studies are required to
study their contribution.
In summary, the present study shows TRPM2 activation
during reperfusion as a crucial mechanism responsible for the
delayed increases in the [Zn2+]c that drives transient ischemia-
induced CA1 pyramidal neuronal death and memory impair-
ments, and suggests that TRPM2 inhibition is a promising
strategy of developing novel therapeutic treatments to mitigate
the cognitive sequelae following transient ischemia or stroke.
Materials and Methods
Mice. TRPM2-KO mice were generated in the C57BL/6 background as detailed in
our recent study.52 WT and TRPM2-KO mice were housed under standard
conditions with a 12/12 h light/dark cycle and free access to food and water. All
animal use procedures were approved by the Committees at Zhejiang University
and Leeds University for the Care and Use of Laboratory Animals. All the
experiments were performed at room temperature or specifically indicated. The
behavioral studies and the analysis of images were performed double-blindly
without the knowledge of the treatments given to the animals.
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Figure 8 TRPM2 deficiency attenuates ROS generation after transient global
ischemia. (a) Representative images of dHEt staining of hippocampal slices from
BCCAO- or sham-operated WTand TRPM2-KO mice. (b) Summary of dHEt staining
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BCCAO and reperfusion. The bilateral common carotid arteries in 8- to
12-week-old male mice were disclosed by incision and occluded using microaneurysm
clips for 15 min under 2% isoflurane in a mix gas of 70% N2O/30% O2 using a face
mask. The body temperature was maintained at 37± 0.5 °C by a heating pad during
surgery by monitoring rectal temperature with a digital thermometer. After blood flow
was restored and incision sutured, the mice were kept at 37± 2 °C for ≥ 4 h and
recovered under normal housing conditions for the indicated time. The cerebral
blood flow was monitored by the laser Doppler flowmetry (Moor, Devon, UK) to
confirm the ceasing and restoration of blood flow. The survival rate was calculated
at 12, 24, 48 and 72 h after BCCAO operation.
Hippocampal neuron culture. Hippocampal tissues from postnatal
day 1 mice were chopped and digested in 0.5% trypsin in Hank's balanced salt
solution (HBSS) at 37 °C for 13 min. Dissociated cells were plated at 1 × 105/cm2 in
poly-L-lysine-coated 35-mm dishes and incubated in the Neurobasal medium
containing 0.5 mM glutamax, 50 U/ml penicillin, 50 μg/ml streptomycin and 2% B27
(Invitrogen, Carlsbad, CA, USA) for 3 days. Cells were maintained in the
Neurobasal medium containing 2.5 μM cytosine arabinofuranoside, which was
replaced every 4 days.
Immunostaining, Nissl and TSQ staining. Mice were anesthetized with
sodium pentobarbital and killed at 24, 48 and 72 h after BCCAO, respectively. For
immunostaining, brains were fixed with 4% paraformaldehyde and cut into 30-μm-
thick coronal sections (1.58–2.18 mm posterior to Bregma) using a Leica CM3050S
cryostat (Leica Biosystems, Mannheim, Germany). After blocking with goat serum in
phosphate-buffered saline (PBS) containing 0.2% Triton X-100 for 1 h, slices were
incubated with rabbit anti-TRPM2 (Abcam, Cambridge, UK; 1 : 200), mouse anti-
CaMKII (Abcam; 1 : 500), mouse anti-GFAP (Invitrogen; 1 : 200) or guinea-pig anti-
NeuN (Millipore, Billerica, MA, USA; 1 : 1000) at 4 °C overnight, and then with Alexa
Flour 546 anti-rabbit IgG, Alexa Flour 546 anti-guinea-pig IgG or Alexa Flour 488
anti-mouse IgG antibody (Invitrogen; 1 : 1000) for 1 h, followed with DAPI staining
(Invitrogen; 1 : 10 000) for 15 min in some experiments. Nissl staining was
performed according to the manufacturer’s instructions (Beyotime, Suzhou, China).
For TSQ and Nissl staining, brains were frozen and cut into 20-μm-thick coronal
sections. Air-dried slices were stained with 100 μM TSQ (Molecular Probes,
Invitrogen) for 90 s and, after the fluorescent images were captured, stained with
Nissl. Images were captured using an Olympus FV1000 confocal microscope
(Olympus, Tokyo, Japan) and Image-Pro Plus (Media Cybernetics, Inc., Bethesda,
MD, USA).
For immunostaining of single cultured hippocampal neurons, cells were seeded at
a density of ~ 65 cells/mm2 on 13-mm poly-L-Lysine-coated coverslips placed in 24-
well plates and cultured for 21 days in vitro (DIV). Cells were incubated in fixing
solution (PBS containing 4% paraformaldehyde and 4% sucrose) for 10 min. After
washing in PBS, cells were incubated with blocking serum solution (PBS containing
5% BSA and 0.4% Triton X-100) for 1 h at room temperature. Cells were incubated
with rabbit anti-TRPM2 antibody (Bethyl, Montgomery, TX, USA; 1 : 1000) and mouse
anti-Neuro-ChromTM Pan Neuronal Marker antibody (Millipore; 1 : 100) in blocking
serum solution at 4 °C overnight and, after washing in PBS, incubated with
fluorescein isothiocyanate-conjugated anti-rabbit IgG secondary antibody (Sigma,
St. Louis, MO, USA; 1 : 600) for 1 h. Cells were washed with PBS and incubated with
tertramethylrhodamine isothiocyanate-conjugated anti-mouse IgG secondary anti-
body (Sigma; 1 : 500) for 1 h. After cells were washed with PBS and rinsed in water,
coverslips were mounted with SlowFade Gold antifade reagent with DAPI (Invitrogen)
and kept in 4 °C overnight. Fluorescent images were captured using an inverted
LSM700 microscope (Carl Zeiss, Jena, Germany).
Acute brain slice preparation. Four-week-old male mice were anesthetized
with diethyl ether and brains were cut into 300-μm-thick transverse slices using a
Leica 1200S vibrotome (Mannheim, Germany) in ice-cold solutions (in mM: 2.5 KCl,
7 MgSO4, 0.5 CaCl2, 1.25 NaH2PO4, 25 NaHCO3, 10 glucose and 210 sucrose, pH
7.3). Slices were firstly incubated at 34 °C to recover for 30 min and then at room
temperature for ≥ 45 min in artificial cerebral spinal fluid (ACSF) (in mM: 119 NaCl,
2.5 KCl, 1 NaH2PO4, 26.2 NaHCO3, 2.5 CaCl2, 1.3 MgSO4 and 11 glucose, pH 7.3)
bubbled with 95% O2/5% CO2.
Patch-clamp recording. Whole-cell currents were recorded from cultured
hippocampal neurons or acute brain slices, using an Axopatch 200B or Multiclamp
700B amplifier (Molecular Devices, Sunnyvale, CA, USA) and protocols as
described previously.32 Intracellular solution for recording cultured neurons
contained (in mM): 147 Cs-gluconate, 10 HEPES, 2 MgCl2 and 1 ADPR (pH
7.3) and extracellular solution: 147 NaCl, 2 KCl, 10 HEPES, 13 glucose, 2 CaCl2
and 0.2 μM TTX (pH 7.4). Intracellular solution for recording brain slices contained
(in mM): 135 CsMeSO4, 8 NaCl, 10 HEPES, 4 MgATP, 0.3 EGTA, 0.3 ADPR and
5 QX314 (pH 7.3), and Mg2+-free ACSF was used as an extracellular solution.
Clotrimazol at 20 μM was diluted in an extracellular solution. The signals were
filtered at 2 kHz and digitized at 10 kHz.
Open-field test. The open-field test was conducted in an open plastic chamber
(45 cm × 45 cm × 45 cm). Mice were individually placed in the corner of the chamber
and allowed to freely explore for 15 min. The locomotor activity of the animals in the
field was measured using an automated video-tracking system (ViewPoint, Lyon,
France). Measurement began immediately after placement in the chamber. The total
distance mice traveled was calculated, and the accumulative time mice spent in the
central square of the open plastic chamber was used as an indicator for exploratory
ability.
Novelty environment habituation test. Similar to the open-field test, the
mice were placed in an open plastic chamber (45 cm × 45 cm × 45 cm) and allowed
to move freely for 5 min, and their locomotor activities were monitored using a
ViewPoint video-tracking system. This test was repeated further two times to
examine their memory of the pre-exposed chamber environments, and the mice
were subjected to sham or BCCAO operation after the second test. The novelty
environment habituation score was presented as the locomotion activity during the
second and third tests as the percentage of that during the first test.
Water maze test. This spatial learning and memory test was conducted as
described in a previous study.53 In brief, the circular water maze tank of 100 cm in
diameter and 60 cm deep was filled with water and the water temperature was
maintained at 22± 1 °C. The water was opaque by adding white and non-toxic
paint. A 10-cm diameter escape platform was submerged 0.5 cm below the water
surface in a fixed position. Distinct cues were painted on the walls. The whole
procedure was performed over a period of 6 days, composed of a training session
during the first 5 days and the probe test on the last day. Each mouse, 7 days after
sham or BCCAO operation, was trained four trails with a 30- s intertrial interval for
each day during the training session. The mouse was placed in one of the four
random start locations facing the wall. The trial was complete when the mouse
touched the platform or 60 s elapsed. If the mouse failed to find the platform with the
limited time during a given trial, it was moved onto the platform by the experimenter.
The probe test lasted for 60 s and was conducted 24 h after the last training using
the same water tank with the escape platform removed. The latency for mice to
reach the escape platform during the training and the time mice spent searching for
the missing escape platform in the target quadrant during the probe test were
recorded and analyzed using an automated tracking system (Coulbourn Instrument,
Whitehall, PA, USA; ACTIMETRICS software, Wilmette, IL, USA).
In situ detection of ROS production. The production of superoxide in situ
was detected as follows. Dihydroethidium (dHEt) (Invitrogen) at 1 mg/kg mouse
weight was injected intraperitoneally at the beginning of BCCAO. Mice were killed
3.5, 24, 48 and 72 h after termination of BCCAO and reperfusion and fixed with 4%
PFA in PBS, respectively. The brain was fixed further in 4% PFA overnight. Three
hippocampal sections with 150 μm intervals were prepared (Vibrotome 1000 plus,
Royston, Herts, UK). The image was captured by a confocal fluorescent microscope
with excitation at 510–550 nm and emission at 580 nm. Ethidium signal intensity
was expressed as the mean fluorescence in neuronal body in the hippocampal CA1
region. Data were obtained from three independent experiments.
OGD and reperfusion. Glucose-free ACSF with glucose replaced with NaCl
and normal ACSF were bubbled, 30 min before and during use, with 95% N2/5%
CO2 or 95% O2/5% CO2, respectively. Acute brain slices were perfused in normal
ACSF for 30 min, glucose-free ACSF for 1 h and then washed with normal ACSF for
30 min, whereas the control slices remained in normal ACSF for 2 h. The slices
were then incubated for 10 min in normal ACSF containing 5 μg/ml propidium iodide
(PI) and 20 μM Newport Green (Invitrogen). Fluorescence images were captured
using an Olympus FV1000 confocal microscope and Zn2+ fluorescence intensity
was measured using ImageJ software (NIH, Bethesda, MD, USA), and PI-stained
cells were counted in the same stratum pyramidal layer of the CA1 region. Data
were from at least three independent experiments.
Role of ROS-sensitive TRPM2
M Ye et al
10
Cell Death and Disease
Cell imaging. Hippocampal neurons of 12–14 DIV were incubated with 1 μM
FluoZin3-AM and 0.02% F127 (Invitrogen) at 37 °C for 1 h and maintained for
another hour in normal solutions (in mM:129 NaCl, 5 KCl, 3 CaCl2, 1 MgCl2, 10
glucose and 10 HEPES, pH 7.4). Neurons were perfused for 60 min with glucose-
free solution (in mM: 140 NaCl, 5 KCl, 3 CaCl2, 0.05 glycine and 10 HEPES, pH
7.4) saturated with 95% N2/5% CO2 and then normal solution for 10 min. In some
experiments, 100 μM CaEDTA or 25 μM Naspm was included. DIV14 hippocampal
neurons used to study H2O2-induced changes in the [Zn
2+]c were loaded with 1 μM
FluoZin3-AM in a similar manner in HBSS. Neurons were exposed to H2O2 at 100
or 300 μM for 40 min, followed by treatment with 10 μM TPEN for 10 min in some
experiments. Fluorescence images were captured using an Olympus FV1000
confocal microscope or a Zeiss M510 confocal microscope (Carl Zeiss) and
fluorescence intensity was measured using ImageJ software. Data were from at
least three independent experiments.
Single-cell imaging of Zn2+ influence in a Tet-inducible HEK293 cells conditionally
expressing TRPM2 was carried out as described above for cultured hippocampal
neurons using extracellular solutions (in mM: 147 NaCl, 2 KCl, 2 CaCl2, 1 MgCl2, 13
glucose and 10 HEPES, pH 7.4) that contained no or 10 μM ZnCl2. The cells were
maintained in DMEM/F-12 (Invitrogen) supplemented with 10% fetal bovine serum
and GlutaMaxTM-1 (Gibco, Life Technologies, Paisley, UK), 5 μg/ml blasticidin
(Invitrogen) and 400 μg/ml zeocin (Invitrogen). Expression of TRPM2 was induced by
removing blasticidin and zeocin and adding 1 μg/ml Tet in the culture medium. Cells
were seeded onto 35-mm glass-bottomed dishes (FluoroDish; World Precision
Instruments, Sarasota, FL, USA) and grown to ~ 60% confluency. Total fluorescence
intensity was measured with ImageJ software. Data were from at least three
independent experiments.
Real-time RT-PCR. Total RNA was extracted from 20–30 mg of the
hippocampus from each mouse using the RNeasy Mini-prep Kit according to the
manufacturer’s instructions (Takara, Dalian, China). Real-time RT-PCR analysis was
performed in four duplicates for each sample using the QPCR SYBR Green
Fluorescein Mix (Takara) and a CFX-96 Thermal Cycler (Bio-Rad, Hercules, CA,
USA). In all, 500–2000 ng of mRNA was reverse-transcribed using the OmniScript
Kit (Takara). Each PCR reaction contained 2 μl of diluted (1 : 10) cDNA, primers
(0.4 μM each) and dNTPs (0.35 μM each). The PCR protocols were composed of
one initial step of 95 °C for 2 min, 40 cycles of 95 °C for 30 s, 60 °C for 30 s and 72 °
C for 30 s, and one additional step of 72 °C for 10 min. The forward and reverse
primer sequences used were as follows: 5′-TACTGGGCACAGTGAATGG-3′ and
5′-GCAAGGCTAAGGAGAAGACC-3′ for ZnT1; 5′-ATGCTCATTAGCCTCTTCGC-3′
and 5′-CTGTCGTCACGGCTGTTCC-3′ for ZnT2; 5′-TTCCACCACTGCCACA
AG-3′ and 5′-TGCTAAATACCCACCAACCA-3′ for ZnT3; 5′-TCCTCCAGACAACA
CCACC-3′ and 5′-AGCCAATGAGCCAAATCC-3′ for ZnT6; 5′-CAGGCTATGCTTGA
TGCTCT-3′ and 5′-GGTTGGACCTTGTTTAGTGTTAT-3′ for TRPM7; and 5′-AGA
GTGTTTCCTCGTCCCG-3′ and 5′-CCGTTGAATTTGCCGTGA-3′ for glyceralde-
hyde- 3-phosphate dehydrogenase (GAPDH). The intensity relative to GAPDH was
estimated by the ΔΔCT method. The size of PCR products was confirmed by
agarose gel analysis. The data from four duplicates were averaged, and the average
value from the TRPM2-KO mice was normalized to that in the matched WT mice in
each independent experiment before the mean value was obtained from all the mice
examined.
Data analysis. All data are presented with mean±S.E.M. where appropriate.
Damaged neurons identified by condensed cell body and nuclei in Nissl staining,
NeuN-positive neurons and GFAP-positive glial cells were counted within an area of
0.2 mm2 randomly chosen for three adjacent fields. The TSQ intensity in CA1
pyramidal neurons was normalized to that in lateral ventricles. The changes in the
[Zn2+]c in individual neurons and HEK293 cells were expressed relative to the basal
level. Statistical analysis was performed using Student’s t-test or one-way ANOVA
followed by post hoc Tukey's test, with Po0.05 being considered statistically significant.
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